HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1
AuthorsAbad-Fernández, M. et al
JournalViruses
PubMed ID36366570
'People living with HIV-1 and HTLV-2 concomitantly show slower CD4+ T cell depletion and AIDS progression, more frequency of the natural control of HIV-1, and lower mortality rates. A similar beneficial effect of this infection has been reported on HCV coinfection reducing transaminases, increasing the spontaneous clearance of HCV infection ... More
HTLV-2 Enhances CD8(+) T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1.
AuthorsAbad-Fernández M,Hernández-Walias FJ,Ruiz de León MJ,Vivancos MJ,Pérez-Elías MJ,Moreno A,Casado JL,Quereda C,Dronda F,Moreno S,Vallejo A
JournalViruses
PubMed ID36366570
People living with HIV-1 and HTLV-2 concomitantly show slower CD4(+) T cell depletion and AIDS progression, more frequency of the natural control of HIV-1, and lower mortality rates. A similar beneficial effect of this infection has been reported on HCV coinfection reducing transaminases, increasing the spontaneous clearance of HCV infection ... More
The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
'Cellular and antibody-mediated rejection processes and also interstitial fibrosis/tubular atrophy (IFTA) lead to allograft dysfunction and loss. The search for accurate, specific and non-invasive diagnostic tools is still ongoing and essential for successful treatment of renal transplanted patients. Molecular markers in blood cells and serum may serve as diagnostic tools ... More